Effect of region on the Outcome of Patients Receiving PD-1/PD-L1 Inhibitors for Advanced Cancer.
Wang Z, Zhang B, Zhang C, Ren S, Wang W, Wang Y, Jiang T, Wei H, Li Y, Wu Q, Chen J.
Wang Z, et al. Among authors: wang w, wang y.
Int Immunopharmacol. 2019 Sep;74:105709. doi: 10.1016/j.intimp.2019.105709. Epub 2019 Jul 2.
Int Immunopharmacol. 2019.
PMID: 31276976
Review.